Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Allergic Reactions Urticaria was reported in 0.7% of SAXENDA-treated patients and 0.5% of placebo-treated patients
GLP-1RAs reduce risks of neurocognitive, substance use, cardiovascular and respiratory disorders, but increase risks of gastrointestinal issues, hypotension and pancreatitis
The same company is currently studying its use in hemorrhagic shock
Wegovy is FDA-approved to reduce excess body weight and maintain weight reduction long term in: adults and pediatric patients aged 12 years and older with obesity, and adults with overweight in the presence of at least one weight-related comorbid condition
US$ 23.17
US$ 24.15
US$ 26.05
US$ 21.43
US$ 22.24
